Dr. Arvin George is a urologic surgeon specializing in the diagnosis and management of genitourinary cancers. He currently serves as an Associate Professor of Urology and Director of Prostate Cancer Programs at the Johns Hopkins School of Medicine. After obtaining his medical degree from the Royal College of Surgeons in Ireland, he completed his Urology Residency at the Smith Institute for Urology, Hofstra North Shore-LIJ School of Medicine. He also completed his Endourology fellowship in New York gaining additional subspecialty expertise in robotic, laparoscopic, and percutaneous surgery. Subsequently, he completed a Urologic Oncology fellowship at the National Cancer Institute, National Institutes of Health. Dr. George’s clinical practice includes both surgical and non-operative management of prostate, kidney, and upper tract urothelial cancers. His research interests include minimally invasive and image-guided treatments, functional prostate imaging and focal therapy for prostate cancer.

Professor Henk van der Poel is head of the department of urology at the Netherlands Cancer Center in Amsterdam (NL) and endowed-professor the Free-University, Amsterdam (NL). Main focuses of research are the role of image-guided surgery in the management of urological oncological diseases and the perioperative network cancer-care for prostate cancer. He is editor-in-chief of the Dutch Journal of Urology.

Dr. Arvin George is a urologic surgeon specializing in the diagnosis and management of genitourinary cancers. He currently serves as an Associate Professor of Urology and Director of Prostate Cancer Programs at the Johns Hopkins School of Medicine. After obtaining his medical degree from the Royal College of Surgeons in Ireland, he completed his Urology Residency at the Smith Institute for Urology, Hofstra North Shore-LIJ School of Medicine. He also completed his Endourology fellowship in New York gaining additional subspecialty expertise in robotic, laparoscopic, and percutaneous surgery. Subsequently, he completed a Urologic Oncology fellowship at the National Cancer Institute, National Institutes of Health. Dr. George’s clinical practice includes both surgical and non-operative management of prostate, kidney, and upper tract urothelial cancers. His research interests include minimally invasive and image-guided treatments, functional prostate imaging and focal therapy for prostate cancer.

Urologist- Nepean Hospital Senior Clinical Lecturer- Sydney University

Urologist- Nepean Hospital Senior Clinical Lecturer- Sydney University

Tim Showalter, MD, MPH, is Chief Medical Officer at ArteraAI a Professor of Radiation Oncology at the University of Virginia and. At ArteraAI, he oversees clinical development and evidence generation for multimodal AI biomarkers, including the ArteraAI Prostate Test, which is guideline-recommended and CMS-reimbursed. At UVA, he maintains a clinical practice and previously led research programs in prostate, breast, and gynecologic cancers, publishing over 190 peer-reviewed articles. Dr. Showalter has led NCI-funded clinical trials, founded a medical device startup (Advaray) acquired by CQ Medical, and is active in national research groups focused on outcomes and brachytherapy.

Ymer is a resident at St George Hospital. He has a particular interest in prostate cancer and focal therapy.

Current urology registrar at The Royal Melbourne Hospital and Master of Surgery candidate at The University of Melbourne.

Third year surgical resident with a special interest in urology.